Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

Abstract

SummaryBackgroundCancer survival is a key measure of the effectiveness of health-care systems. Persistent regional and international differences in survival represent many avoidable deaths. Differences in survival have prompted or guided cancer control strategies. This is the first study in a programme to investigate international survival disparities, with the aim of informing health policy to raise standards and reduce inequalities in survival.MethodsData from population-based cancer registries in 12 jurisdictions in six countries were provided for 2·4 million adults diagnosed with primary colorectal, lung, breast (women), or ovarian cancer during 1995–2007, with follow-up to Dec 31, 2007. Data quality control and analyses were done centrally with a common protocol, overseen by external experts. We estimated 1-year and 5-year relative survival, constructing 252 complete life tables to control for background mortality by age, sex, and calendar year. We report age-specific and age-standardised relative survival at 1 and 5 years, and 5-year survival conditional on survival to the first anniversary of diagnosis. We also examined incidence and mortality trends during 1985–2005.FindingsRelative survival improved during 1995–2007 for all four cancers in all jurisdictions. Survival was persistently higher in Australia, Canada, and Sweden, intermediate in Norway, and lower in Denmark, England, Northern Ireland, and Wales, particularly in the first year after diagnosis and for patients aged 65 years and older. International differences narrowed at all ages for breast cancer, from about 9% to 5% at 1 year and from about 14% to 8% at 5 years, but less or not at all for the other cancers. For colorectal cancer, the international range narrowed only for patients aged 65 years and older, by 2–6% at 1 year and by 2–3% at 5 years.InterpretationUp-to-date survival trends show increases but persistent differences between countries. Trends in cancer incidence and mortality are broadly consistent with these trends in survival. Data quality and changes in classification are not likely explanations. The patterns are consistent with later diagnosis or differences in treatment, particularly in Denmark and the UK, and in patients aged 65 years and older.FundingDepartment of Health, England; and Cancer Research UK.

Breast Cancer in Iraq, Incidence Trends from 2000-2009

“…This mean is higher to other Arab and regional countries, such as Saudi Arabia (47-48.6 years) (Amin et al, 2009), (Al-Rikabi andHusain, 2012), (Montazeri et al, 2008), (Asadzadeh et al, 2012), (Kooshyar et al, 2013). While the mean age at diagnosis for women in (Australia, Canada, Denmark, Norway, Sweden, andthe UK, 1995-2007) was 62·5 years (range 60.6-63.9 years) (Coleman et al, 2011).…”

Psychological Problems Experienced by Women with Gynecological Cancer and How They Cope with It: A Phenomenological Study in Turkey

“…Despite improvements in surgery, chemotherapy, and targeted therapy, women with advanced ovarian cancer, which cannot be diagnosed early, face poor prognoses, with more than 50 percent of them dying within five years of diagnosis ( Coleman et al, 2011). Gynecological cancer has many psychological effects on women's health.…”

Low Lung Cancer Resection Rates in a Tertiary Level Thoracic Center in Nepal - Where Lies Our Problem?

“…Despite efforts at screening, fast tract investigation and treatment of lung cancer; the resection rates for lung cancer worldwide are not high (Damhuis et al, 1995). The reported rates of lung cancer resection stands around 25% in the United States (Dransfield et al, 2006) and 20% in Europe (Coleman et al, 2011). Studies carried out in the U.K. found in 1990's the resection rates in Great Britain to be around 10%, far less than the average of the western Europe (Damhuis et al, 1995).…”